Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/51456
Full metadata record
DC FieldValueLanguage
dc.contributor.authorL. Stranix-Chibandaen_US
dc.contributor.authorS. Brummelen_US
dc.contributor.authorJ. Pilottoen_US
dc.contributor.authorM. Mutambanengween_US
dc.contributor.authorV. Chanaiwaen_US
dc.contributor.authorT. Mhembereen_US
dc.contributor.authorM. Kamateekaen_US
dc.contributor.authorJ. Aizireen_US
dc.contributor.authorG. Mashetoen_US
dc.contributor.authorR. Chamangaen_US
dc.contributor.authorM. Maluwaen_US
dc.contributor.authorS. Hanleyen_US
dc.contributor.authorE. Joaoen_US
dc.contributor.authorG. Theronen_US
dc.contributor.authorN. Nevrekaren_US
dc.contributor.authorM. Nyatien_US
dc.contributor.authorB. Santosen_US
dc.contributor.authorL. Aurpibulen_US
dc.contributor.authorM. Mubiana-Mbeween_US
dc.contributor.authorR. Oliveiraen_US
dc.contributor.authorT. Anekthananonen_US
dc.contributor.authorP. Mlayen_US
dc.contributor.authorK. Angelidouen_US
dc.contributor.authorC. Tierneyen_US
dc.contributor.authorL. Ziembaen_US
dc.contributor.authorA. Colettien_US
dc.contributor.authorK. McCarthyen_US
dc.contributor.authorM. Basaren_US
dc.contributor.authorN. Chakhtouraen_US
dc.contributor.authorR. Browningen_US
dc.contributor.authorJ. Currieren_US
dc.contributor.authorM. G. Fowleren_US
dc.contributor.authorP. Flynnen_US
dc.contributor.otherFHI 360en_US
dc.contributor.otherBotswana Harvard AIDS Institute Partnershipen_US
dc.contributor.otherCentre for the AIDS Programme of Research in South Africaen_US
dc.contributor.otherFrontier Science & Technology Research Foundation, Inc.en_US
dc.contributor.otherCentre for Infectious Disease Research in Zambiaen_US
dc.contributor.otherUNC Project-Malawien_US
dc.contributor.otherUniversity of Malawi College of Medicineen_US
dc.contributor.otherMakerere Universityen_US
dc.contributor.otherKilimanjaro Christian Medical Centreen_US
dc.contributor.otherHospital Nossa Senhora da Conceicaoen_US
dc.contributor.otherHospital Geral de Rio de Janeiroen_US
dc.contributor.otherUniversity of Zimbabween_US
dc.contributor.otherUniversity of California, Los Angelesen_US
dc.contributor.otherSt. Jude Children's Research Hospitalen_US
dc.contributor.otherNational Institute of Child Health and Human Developmenten_US
dc.contributor.otherNational Institute of Allergy and Infectious Diseasesen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherCenter for Biostatistics in AIDS Researchen_US
dc.contributor.otherUniversiteit Stellenboschen_US
dc.contributor.otherJohns Hopkins School of Medicineen_US
dc.contributor.otherUniversidade Federal do Rio de Janeiroen_US
dc.contributor.otherBJ Government Medical Collegeen_US
dc.contributor.otherHospital Federal dos Servidores do Estadoen_US
dc.contributor.otherChiang Mai Universityen_US
dc.contributor.otherPerinatal HIV Research Uniten_US
dc.date.accessioned2020-01-27T09:34:35Z-
dc.date.available2020-01-27T09:34:35Z-
dc.date.issued2019-09-01en_US
dc.identifier.citationAIDS and Behavior. Vol.23, No.9 (2019), 2522-2531en_US
dc.identifier.issn15733254en_US
dc.identifier.issn10907165en_US
dc.identifier.other2-s2.0-85070339824en_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/51456-
dc.description.abstract© 2019, The Author(s). The PROMISE trial enrolled asymptomatic HIV-infected pregnant and postpartum women not eligible for antiretroviral treatment (ART) per local guidelines and randomly assigned proven antiretroviral strategies to assess relative efficacy for perinatal prevention plus maternal/infant safety and maternal health. The START study subsequently demonstrated clear benefit in initiating ART regardless of CD4 count. Active PROMISE participants were informed of results and women not receiving ART were strongly recommended to immediately initiate treatment to optimize their own health. We recorded their decision and the primary reason given for accepting or rejecting the universal ART offer after receiving the START information. One-third of participants did not initiate ART after the initial session, wanting more time to consider. Six sessions were required to attain 95% uptake. The slow uptake of universal ART highlights the need to prepare individuals and sensitize communities regarding the personal and population benefits of the “Treat All” strategy.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070339824&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSlow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globeen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.1007/s10461-019-02624-3en_US
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070339824&origin=inwarden_US
Appears in Collections:Scopus 2019

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.